Actinium Pharmaceuticals
ATNM
ATNM
55 hedge funds and large institutions have $21.1M invested in Actinium Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
12% more funds holding
Funds holding: 49 → 55 (+6)
1% more ownership
Funds ownership: 10.37% → 11.37% (+1%)
Holders
55
Holding in Top 10
–
Calls
$3.44M
Puts
$2.23M
Top Buyers
| 1 | +$1.1M | |
| 2 | +$666K | |
| 3 | +$309K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$294K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$205K |
Top Sellers
| 1 | -$325K | |
| 2 | -$306K | |
| 3 | -$171K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$151K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$91.1K |